[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f-106Db3dptp9-8CNgVdVVA8b_xfPci4LAr-0mNFtQc0":3},{"id":4,"source":5,"question":6,"options":7,"answer":12,"related":13,"type":24,"origin":111,"createTime":26},165376450,"v1","关于药物临床试验管理的说法,错误的是",[8,9,10,11],"临床试验应符合伦理道德标准,药物临床试验方案必须经过伦理委员会审查批准","应保证受试者在自愿参与前被告知足够的试验信息,理解并签署知情同意书","新药上市前须完成IV期临床试验,以充分考察评价该新药的收益与风险关系","试验药物应在符合《药品生产质量管理规范》的车间制备",[],[14,27,37,47,57,67,77,87,97,107],{"id":15,"source":5,"question":16,"options":17,"answer":22,"related":23,"type":24,"origin":25,"createTime":26},165376423,"药品注册证书的有效期及申请药品再注册的期限分别是",[18,19,20,21],"5年、有效期届满前6个月","3年、有效期届满前3个月","5年、有效期届满前3个月","3年、有效期届满前6个月",[],[],1,null,"2024-11-10T23:28:18+08:00",{"id":28,"source":5,"question":29,"options":30,"answer":35,"related":36,"type":24,"origin":25,"createTime":26},165376427,"下列关于药品上市许可持有人的说法错误的是",[31,32,33,34],"药品上市许可持有人是指取得药品注册证书的企业、个人或者药品研制机构","药品上市许可持有人的身份是由申请人转变而来的","药品上市许可持有人应当具备保障药品安全性、有效性和质量可控性的质量管理、风险防控和责任赔偿等能力","药品上市许可持有人是药品安全的第一责任人",[],[],{"id":38,"source":5,"question":39,"options":40,"answer":45,"related":46,"type":24,"origin":25,"createTime":26},165376432,"国家鼓励仿制的药品不包括",[41,42,43,44],"临床必需的仿制药","重大传染病防治治疗所需药品","儿童使用药品","孕妇使用药品",[],[],{"id":48,"source":5,"question":49,"options":50,"answer":55,"related":56,"type":24,"origin":25,"createTime":26},165376435,"负责药品注册管理工作,制定药品注册管理规范的部门是",[51,52,53,54],"国家药品监督管理局","国家卫生健康委员会","国家医疗保障局","国家中医药管理局",[],[],{"id":58,"source":5,"question":59,"options":60,"answer":65,"related":66,"type":24,"origin":25,"createTime":26},165376438,"药品上市许可申请时,临床急需的短缺药品、罕见病和防治重大传染病等疾病的创新药及改良型新药,可以申请适用",[61,62,63,64],"附条件批准程序","优先审评审批程序","突破性治疗药物程序","特别审批程序",[],[],{"id":68,"source":5,"question":69,"options":70,"answer":75,"related":76,"type":24,"origin":25,"createTime":26},165376441,"根据《药品管理法》,可以成为药品上市许可持有人的是",[71,72,73,74],"取得《药品经营许可证》的药品经营企业","取得《医疗机构执业许可证》的医疗机构","取得药品注册证书的药品研制机构","取得《药品生产许可证》的药品生产企业",[],[],{"id":78,"source":5,"question":79,"options":80,"answer":85,"related":86,"type":24,"origin":25,"createTime":26},165376444,"关于药品不良反应的报告和监测管理,说法错误的是",[81,82,83,84],"药品上市许可持有人是药品安全责任的主体","药品上市许可持有人应开展上市后不良反应监测,主动收集、跟踪分析疑似药品不良反应的信息","以批准上市的药品安全性报告应当自取得批准证明文件之日起以后每满1年都要提交一次定期安全性更新报告","药品经营企业直接向药品上市许可持有人报告",[],[],{"id":88,"source":5,"question":89,"options":90,"answer":95,"related":96,"type":24,"origin":25,"createTime":26},165376446,"开办药品生产企业应具备的条件不包括",[91,92,93,94],"具有保证药品质量的规章制度","具有依法经过资格认定的药学技术人员","具有能对所生产药品进行质量管理、质量检验和研发的机构","具有与其药品生产相适应的厂房、设施、设备和卫生环境",[],[],{"id":98,"source":5,"question":99,"options":100,"answer":105,"related":106,"type":24,"origin":25,"createTime":26},165376448,"关于药品上市许可持有人的权利和义务,说法错误的是",[101,102,103,104],"是药品安全的第一责任人","应当建立年度报告制度","转让药品上市许可须经所在地省级药品监督管理部门批准","建立药品上市放行规程,药品生产企业出厂的药品须经质量受权人签字后方可放行",[],[],{"id":4,"source":5,"question":6,"options":108,"answer":109,"related":110,"type":24,"origin":25,"createTime":26},[8,9,10,11],[],[],{"courseName":112,"courseImg":113,"workName":114,"workId":115,"count":116,"courseId":117},"药事管理与法规","https:\u002F\u002Ftihai-oss-cloud.itihey.com\u002Fimg\u002F172ac4a7c06c96a1b99247f178f85d9c.jpg","","work_38591560",138,"64b7328c362f8a93a651b6066eb7a3dd"]